Compile Data Set for Download or QSAR
maximum 50k data
Found 20 Enz. Inhib. hit(s) with all data for entry = 8008
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228638(US9345793, 19 | US9744252, Example 19)
Affinity DataIC50:  3nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228637(US9345793, 18 | US9744252, Example 18)
Affinity DataIC50:  3nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228634(US9345793, 15 | US9744252, Example 15)
Affinity DataIC50:  5nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228635(US9345793, 16 | US9744252, Example 16)
Affinity DataIC50:  6nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228639(US9345793, 20 | US9744252, Example 20)
Affinity DataIC50:  7nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228632(US9345793, 13 | US9744252, Example 13)
Affinity DataIC50:  7nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228631(US9345793, 12 | US9744252, Example 12)
Affinity DataIC50:  8nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228626(US9345793, 7 | US9744252, Example 7)
Affinity DataIC50:  11nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228627(US9345793, 8 | US9744252, Example 8)
Affinity DataIC50:  14nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228630(US9345793, 11 | US9744252, Example 11)
Affinity DataIC50:  14nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228629(US9345793, 10 | US9744252, Example 10)
Affinity DataIC50:  15nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228633(US9345793, 14 | US9744252, Example 14)
Affinity DataIC50:  15nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228624(US9345793, 5 | US9744252, Example 5)
Affinity DataIC50:  16nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228625(US9345793, 6 | US9744252, Example 6)
Affinity DataIC50:  16nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228622(US9345793, 3 | US9744252, Example 3)
Affinity DataIC50:  20nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228628(US9345793, 9 | US9744252, Example 9)
Affinity DataIC50:  21nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228621(US9345793, 2 | US9744252, Example 2)
Affinity DataIC50:  29nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228636(US9345793, 17 | US9744252, Example 17)
Affinity DataIC50:  35nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228623(US9345793, 4 | US9744252, Example 4)
Affinity DataIC50:  84nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228620(US9345793, 1 | US9744252, Example 1)
Affinity DataIC50:  101nMT: 2°CAssay Description:The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent